[Chinard Bloodrporation Reports Financial Results for the First Quarter of Fiscal 2014 1Q14ded 15,260 New Subscribers 1Q14 Revenue Up 11.6% YOY to RMB128.7 Million 1Q14 Operatingome Up 3.3% YOY to RMB45.9 Millionnferencell to be Held August 27, 2013 at 8:00 a.m. ET HONG KONG, China, August 26, 2013 -- Chinard Bloodrporation (NYSE:) (CCBC or thempany),]
[Description 99.1 Announcement on 2013/08/02: To announce UMC will convene 2Q2013 investor conferences on 2013/08/07 99.2 Announcement on 2013/08/06: To announce related materials on acquisition of machinery and equipment 99.3 Announcement on 2013/08/07: To announce unconsolidated operating results for the second quarter of 2013 99.4 Announcement on 2013/08/16: To announce related materials on disposal of common shares of PARADE TECHNOLOGIES] [FORM 6-K August 26, 2013 United Microelectronics Corporation No. 3 Li Hsin Road II x x n/a United Microelectronics Corporation Chitung Liu Chitung Liu CFO Description 99 6K on 08/26/2013 6-K 1 htm_7942.htm LIVE FILING]
[Chinard Bloodrporation Reports Financial Results for the First Quarter of Fiscal 2014 1Q14ded 15,260 New Subscribers 1Q14 Revenue Up 11.6% YOY to RMB128.7 Million 1Q14 Operatingome Up 3.3% YOY to RMB45.9 Millionnferencell to be Held August 27, 2013 at 8:00 a.m. ET HONG KONG, China, August 26, 2013 -- Chinard Bloodrporation (NYSE:) (CCBC or thempany),]
[DEHAIER MEDICAL SYSTEMS LIMITED AND AFFILIATE INDEX TO FINANCIAL STATEMENTS UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS PAGE Condensed Consolidated Interim Balance Sheets as of June 30, 2013 and December 31, 2012 F-2 Condensed Consolidated Interim Statements of Income and Comprehensive Income for the Six Months Ended June 30, 2013 and 2012 F-3 Consolidated Interim Statements of Cash Flows for the] [Dehaier Medical Announces 2013 First Half Year Financial Results BEIJING – August 26, 2013 — Dehaier Medical Systems Ltd. (Nasdaq: DHRM) Mr. Ping Chen, Chief Executive Officer of Dehaier Medical, stated, "We are pleased to have expanded into China’s burgeoning sleep respiratory market by entering into a strategic agreement with an Israeli medical signal processing company. As WideMed’s exclusive partner] []
